Entrada Therapeutics
TRDA
TRDA
48 hedge funds and large institutions have $243M invested in Entrada Therapeutics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 6 closing their positions.
Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
0.76%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
8
Increased
14
Reduced
12
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CSS
51
Cubist Systematic Strategies
Stamford,
Connecticut
| – | – | -11,090 | Closed |
|
|
CCM
52
CAAS Capital Management
New York
| – | – | -10,000 | Closed |
|
53
Osaic Holdings
Scottsdale,
Arizona
| – | – | -300 | Closed |
|
|
PHK
54
Point72 Hong Kong
Hong Kong
| – | – | -215 | Closed |
|
|
CFGS
55
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|